ONCOR B/T GENE REARRANGEMENT TEST

Dna-probe, B And T Lymphocyte

FDA Premarket Approval P880016

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

DeviceONCOR B/T GENE REARRANGEMENT TEST
Classification NameDna-probe, B And T Lymphocyte
Generic NameDna-probe, B And T Lymphocyte
ApplicantONCOR, INC.
Date Received1988-03-01
Decision Date1989-10-10
Notice Date1989-11-14
PMAP880016
SupplementS
Product CodeMAM
Docket Number89M-0456
Advisory CommitteeHematology
Expedited ReviewNo
Combination Product No
Applicant Address ONCOR, INC. 209 Perry Pkwy. gaithersburg, MD 20877

Supplemental Filings

Supplement NumberDateSupplement Type
P880016Original Filing
S004 1992-08-26 Normal 180 Day Track
S003 1991-06-07 Normal 180 Day Track
S002 1990-04-10 Normal 180 Day Track
S001 1989-12-18 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.